Both cautious optimism and heated debate were triggered by the FDA’s recent decision to approve leucovorin, also known as folinic acid, for use in a subset of children with autism. During a high-profile press conference with President Trump, Health Secretary Robert F. Kennedy Jr., and Dr. Mehmet Oz, the announcement raised concerns about politics and profit while also highlighting the potential for a new therapy. Critics speculated within hours that Oz, who had previously owned stock in iHerb, a company that sells folinic acid supplements, might profit.
Officials from the Department of Health and Human Services responded swiftly and with remarkable clarity: the approval only applied to prescription leucovorin, not over-the-counter supplements like those offered on iHerb. Although disclosures suggested that stock sales might be postponed until a corporate buyout, Oz himself had made a public commitment to divest. Social media posts implying that the action was “corruption dressed up as wellness” increased public suspicion by creating just enough ambiguity.
The narrative remarkably resembles other instances where celebrity influence and health policy collide. Similar to how Elon Musk’s tweets sent markets reeling or Gwyneth Paltrow’s Goop empire blurred the boundaries between wellness and commerce, Oz’s attendance at the FDA announcement increased levels of scrutiny and attention. Because of his fame, the discussion shifted from science to perception, trust, and the ability of well-known people to influence public opinion.
Dr. Mehmet Oz – Bio & Career Table
| Category | Details |
|---|---|
| Full Name | Mehmet Cengiz Oz |
| Date of Birth | June 11, 1960 |
| Age | 65 |
| Birthplace | Cleveland, Ohio, USA |
| Education | Harvard University (BA), University of Pennsylvania (MD, MBA) |
| Profession | Cardiothoracic surgeon, TV personality, author, politician |
| Political Role | Former U.S. Senate candidate (2022), current Administrator of CMS under Trump (2025) |
| Known For | The Dr. Oz Show, appearances on Oprah, health advocacy |
| Business Links | Past investor in iHerb, supplement retailer |
| Controversies | Criticism over promotion of alternative treatments, supplement endorsements |
| Family | Married to Lisa Oz, four children |
| Reference | Dr. Oz – Wikipedia |
The history of folinic acid itself is lengthy. Since its initial introduction in the 1950s as a supportive treatment for patients undergoing chemotherapy, it has been investigated in smaller clinical trials for children suffering from cerebral folate deficiency. Antibodies that block folate transport may be present in these kids, some of whom are autistic, rendering regular folic acid useless. By avoiding this genetic barrier, folinic acid provides a pathway that is especially advantageous for enhancing development and communication.
Dr. Richard Frye and other researchers have characterized the findings as encouraging but modest, highlighting the fact that science is still at “the 10-yard line.” Similarly, folinic acid is not a cure and needs to be used carefully, even though it can be remarkably effective for the right patients, according to Dr. Karam Radwan of UChicago. If a medication is prescribed without the necessary genetic testing, some kids become agitated or violent. In headlines, where optimism or indignation take precedence over nuance, this warning nuance is frequently overlooked.
The reaction of the customers was expected. The FDA announcement caused a sharp increase in folinic acid supplement sales on iHerb, with many products selling out within days. This quick market response demonstrates how remarkably effective celebrity-related news can be at influencing consumer behavior. Kim Kardashian’s support of beauty products or Tom Brady’s TB12 wellness line are just two examples of the pattern where demand is accelerated by cultural influence long before scientific consensus.
The discovery of folinic acid offered families dealing with autism a glimmer of cautious hope. In an attempt to make progress, many parents have cycled through diets, therapies, and supplements for years. Even small tales of better communication have a profound impact. However, these families also voice concerns about hype, believing that supplement companies may profit from desperate hope more quickly than clinical science can keep up. Within the autism community, where every promising lead is both praised and closely examined, this duality—hope and skepticism entwined—is remarkably resilient.
At the heart of this intricate story is Dr. Oz. His career demonstrates how public figures can be extremely versatile across industries. He was once Oprah’s go-to television doctor, went on to run for the Senate, and is currently a federal health administrator. However, this prominence also draws criticism. His connections to iHerb, despite their distance, create a tension that is remarkably similar to that which other public officials face when juggling the history of the private sector with their public duties.
This case is especially novel because of the cultural setting in which it is taking place as well as the science underlying folinic acid. Politicians are portraying the treatment as a breakthrough, researchers are urging larger trials, and the autism community is very clear in its demands for evidence-based therapies. The question of how much weight to give to celebrity voices in influencing health narratives is also being debated by society.
